Our commitment to patients

Our mission is to improve the lives of patients living with cancer and chronic diseases across the world. We recognize the importance of understanding the challenges faced by patients in order to provide the support they need.

Learn more
Early Access Programs

Access to medicinal products before marketing approval

Helsinn’s Early Access Programs (EAP) allow patients with life threatening conditions access to cancer therapeutic products they would not otherwise have had access to.

Learn More
Educational Grants

Supporting legitimate and independent educational activities

Helsinn is committed to funding programs that communicate relevant scientific information to the medical community with the overall aim of improving patient care.

Learn More